| 1. |
Ruderman I, Toussaint ND, Hawley CM, et al. The Australian Calciphylaxis Registry: reporting clinical features and outcomes of patients with calciphylaxis. Nephrol Dial Transplant, 2021, 36(4): 649-656.
|
| 2. |
Chinnadurai R, Huckle A, Hegarty J, et al. Calciphylaxis in end-stage kidney disease: outcome data from the United Kingdom Calciphylaxis Study. J Nephrol, 2021: 6.
|
| 3. |
刘茁, 纪明开, 陈颖, 等. 闭塞性动脉硬化症误诊为硬皮病 1 例. 中国皮肤性病学杂志, 2005, 19(7): 439-440.
|
| 4. |
Udomkarnjananun S, Kongnatthasate K, Praditpornsilpa K, et al. Treatment of calciphylaxis in CKD: a systematic review and meta-analysis. Kidney Int Rep, 2018, 4(2): 231-244.
|
| 5. |
赖玮婧, 江玉波, 王少清. 下肢钙化防御 1 例并文献复习. 中国皮肤性病学杂志, 2019, 33(7): 811-813.
|
| 6. |
Hayden MR, Goldsmith DJ. Sodium thiosulfate: new hope for the treatment of calciphylaxis. Semin Dial, 2010, 23(3): 258-262.
|
| 7. |
Mccarthy JT, El-Azhary RA, Patzelt MT, et al. Survival, risk factors, and effect of treatment in 101 patients with calciphylaxis. Mayo Clin Proc, 2016, 91(10): 1384-1394.
|
| 8. |
Liu Y, Zhang X, Xie X, et al. Risk factors for calciphylaxis in Chinese hemodialysis patients: a matched case-control study. Ren Fail, 2021, 43(1): 406-416.
|
| 9. |
Gabel CK, Nguyen ED, Chakrala T, et al. Assessment of outcomes of calciphylaxis. J Am Acad Dermatol, 2020, 29: S0190-9622(20)32880-2.
|
| 10. |
Matsumoto T, Tomita K, Suda S, et al. Microballoon-related interventions in various endovascular treatments of body trunk lesions. Minim Invasive Ther Allied Technol, 2018, 27(1): 2-10.
|
| 11. |
吴庆云, 祝艳华. 应用“TIME”原则指导深度压疮创面的修复. 创伤外科杂志, 2017, 19(1): 71-72.
|
